Patient Choice Cards

Prostate Cancer Canada is pleased to partner with InnoviCares and RxHelp One™, two FREE programs sponsored by pharmaceutical manufacturers that give you access to dozens of brand name medications and medical devices at little or no cost versus the generic alternative.

To learn more about these FREE programs, which medications and healthcare products are covered and how you can participate in these programs, simply click on the links below.


InnoviCares

InnoviCares is a FREE patient benefit plan that gives you coverage for a variety of medications, plus savings on many healthcare products – giving you greater access and choice to nearly 100 brand name medications. To see which medications and healthcare products are available to you and to sign up to receive this benefit, click here: https://prostatecancer.innovicares.ca

InnoviCares-Graphic.png


RxHelp One

RxHelp ONE™ is FREE, and gives you access to dozens of brand medications, including treatments for men’s health, all at little or no cost versus the generic alternative. To see what medications are covered and to sign up, click here: www.RxHelpONE.com/PCC

RxHelp One



If you have questions about joining these programs, please contact us: drugcoverage@prostatecancer.ca
 


Prostate Cancer Canada is proud to partner with RxHelp One™ and InnoviCares to offer these FREE programs as another choice for patients who wish to remain on their brand name medications, however, this is not an endorsement. PCC believes patients should choose medications that are right for them based on informed discussions with their healthcare providers.
 

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive